Skip to main content
mBio logoLink to mBio
. 2018 Dec 18;9(6):e02461-18. doi: 10.1128/mBio.02461-18

Exoribonuclease-Resistant RNAs Exist within both Coding and Noncoding Subgenomic RNAs

Anna-Lena Steckelberg a,#, Quentin Vicens a,✉,#, Jeffrey S Kieft a,
Editor: Alexander Idnurmb
Reviewed by: Samuel Butcherc, W Allen Millerd
PMCID: PMC6299227  PMID: 30563900

During infection, viruses often produce subgenomic RNAs (sgRNAs) that either serve as the template for protein synthesis or act as “riboregulators” that interact with and influence the viral and cellular machinery. Recently, a mechanism for producing sgRNAs was found that depends on the presence of specifically structured RNA elements (xrRNAs). However, the degree to which this mechanism is used, where the elements are found, their structural diversity, and what types of sgRNAs are produced by this pathway were unclear. This article describes the discovery of these structured RNA elements in two large families of plant viruses and shows that they are used to produce both protein-coding sgRNAs and “riboregulatory” RNAs. These discoveries provide evidence that xrRNA-based RNA maturation pathways may be more widespread than previously anticipated and that they are involved in producing a variety of RNAs of diverse functions.

KEYWORDS: Infernal, RNA structure, exoribonuclease resistance, plant viruses, viral RNA

ABSTRACT

Many viruses produce protein-coding and noncoding subgenomic RNAs (sgRNAs) that are critical for infection. A recently discovered pathway for viral sgRNA production uses exoribonuclease-resistant RNAs (xrRNAs), discrete folded RNA elements that block the processive exoribonucleolytic degradation of RNA. xrRNAs are widespread in animal-infecting flaviviruses but had been found only in three members of the plant virus genus Dianthovirus. Also, xrRNAs had been found only in the 3′ untranslated regions (3′UTRs) of viral RNAs, where they produce noncoding sgRNAs. The degree to which xrRNA elements exist in other viruses, the conservation of their ring-like fold, and the ability of xrRNAs to operate in diverse contexts were unknown. Using computational tools and biochemical assays, we discovered xrRNA elements pervading two large families of plant-infecting RNA viruses, demonstrating their importance and widespread utility. Comparison of the sequences and functional requirements suggests that all adopt the characteristic ring-like fold. Unexpectedly, many of these newly discovered xrRNAs are located in intergenic regions rather than 3´UTRs, and some are associated with the 5′ ends of subgenomic RNAs that encode viral proteins. This suggests that xrRNAs are involved in the production of both coding and noncoding subgenomic RNAs and can operate as part of broader mechanisms to regulate RNA levels and protein expression. These discoveries expand the potential roles for xrRNAs and suggest that xrRNAs may represent a more general strategy for RNA maturation and maintenance than previously known.

INTRODUCTION

Single-stranded positive-sense RNA viruses include pathogens that infect a wide range of animal and plant hosts, with significant human health, agricultural, and economic impact. During infection, these viruses must generate many copies of their full-length genomic RNA, but many also produce one or more infection-critical subgenomic RNA species (sgRNA). sgRNAs can have different functions: they can encode and serve as the template for production of specific viral proteins or act as noncoding “riboregulators” that interact with and influence the cellular and viral machinery to benefit viral infection (16). Most viral sgRNAs are thought to be produced directly through transcription from internal subgenomic promoters or by premature termination during negative-strand synthesis (4). However, recent discoveries showed that some noncoding viral sgRNAs result from incomplete degradation of the genomic RNA in a pathway depending on discrete, compact RNA structures that block the progression of 5′-to-3´ exoribonucleases (Fig. 1) (715). The full extent of this phenomenon and the diversity of RNA structures that can provide this ability are unknown, and to date all have been associated with noncoding RNA production.

FIG 1.

FIG 1

An expanding repertoire of structured RNAs for blocking exoribonuclease degradation. (Top) xrRNAs adopt a three-dimensional structure that blocks the progression of 5′-to-3′ exoribonucleases such as Xrn1 (gray). In the case of flaviviruses and dianthoviruses, xrRNAs are in the 3′UTR, resulting in accumulating noncoding sgRNAs. (Middle) Secondary structure diagrams of the two classes of xrRNAs from flaviviruses (xrRNAF1 and xrRNAF2) (15, 22, 23) and of xrRNAD from dianthoviruses (26). Secondary structure features are labeled, and nucleotides involved in tertiary interactions are shown in colors connected by dashed lines (pseudoknot shown in blue). Experimentally determined Xrn1 stop sites are indicated. (Bottom) The boxes below each secondary structure contain diagrams reflecting the currently available three-dimensional structures (2426). The A8-G33 pair is highlighted in the open state of the Sweet clover necrotic mosaic virus (SCNMV) xrRNA (far left).

Exoribonuclease-resistant RNA (xrRNA) elements were first identified in mosquito-borne flaviviruses (e.g., dengue virus, Zika virus, West Nile virus), where they protect the genome’s 3′ untranslated region (3′UTR) from degradation (8). The resultant decay intermediates accumulate and comprise biologically active viral noncoding sgRNAs (Fig. 1) (8, 9, 12, 1621). xrRNAs are useful and important elements, as they are broadly found within the 3′UTRs of flaviviruses, including those that are tick-borne; are specific to insects; or have no known vector (15, 22, 23). Comparison and characterization of these diverse flaviviral xrRNA (xrRNAF) sequences revealed two classes; class I (xrRNAF1) is exemplified by mosquito-borne flaviviruses, whereas class II (xrRNAF2) is found in diverse flaviviruses (23). Extensive functional and high-resolution structural studies of xrRNAF1 have shown that function is conferred by a specific three-dimensional (3D) fold containing an interwoven pseudoknot stabilized by conserved secondary and tertiary interactions; this creates an unusual ring-like conformation that protectively wraps around the 5′ end of the RNA structure (24, 25). Although aligned xrRNAF2 sequences show conserved patterns, their 3D structures are unknown (23).

As with xrRNAF2, the structures of recently reported xrRNAs from most other viral clades remain unsolved (7, 13), with the exception of those found in a small genus of plant-infecting RNA viruses. Specifically, we recently characterized the structure and function of xrRNAs from the 3′UTRs of dianthoviruses, which are positive-sense RNA viruses in the Tombusviridae family; similarly to xrRNAF, dianthoviral xrRNAs (xrRNAD) function to produce a noncoding RNA derived from the viral 3′UTR (10, 26). xrRNAD also rely on a pseudoknot that forms a protective ring-like structure (26), but they have very different sequences and secondary structures from those of xrRNAF1, and the ring is formed by a different set of interactions (Fig. 1). The xrRNAD crystal structure is in an “open” conformation that likely represents a folding intermediate whose presence is necessary before the pseudoknot forms (26) (Fig. 1). Thus, we still do not know the full repertoire of secondary and tertiary interactions required to form and stabilize the exoribonuclease-resistant pseudoknot state of xrRNAD. In addition, because only 3 examples are known, the lack of diverse xrRNAD sequences prevents conclusions about the role, prevalence, and structural diversity of this fold.

Because xrRNAF elements pervade the flaviviruses with associated sequence and structural diversity characteristics, it was puzzling that xrRNAD had been identified only in the three closely related members of the Dianthovirus genus. This observation raised the issue of whether xrRNAs similar to xrRNAD are more widespread and diverse than currently known; if so, it would indicate that they represent a more general and perhaps more important way to produce or protect viral RNAs than is currently recognized. This is true in a broader sense as well; the issue of how widespread xrRNAs are across biology remains open.

To begin to address both the specific issue of the presence of xrRNAD in other viruses and the more general issues about xrRNA diversity and distribution, we used a bioinformatic approach to search for more xrRNAD in a variety of plant viruses. We identified over 40 putative new xrRNAD-like elements in viruses belonging to the economically important Tombusviridae and Luteoviridae families. In vitro assays showed that these elements are indeed resistant to Xrn1, and analysis of these new xrRNAs revealed both conservation and variability. Surprisingly, we found many of these xrRNAs in intergenic regions of the viral genomic RNA, where they can be involved in the generation or maintenance of sgRNA species with protein-coding potential; hence, xrRNAs are not limited to noncoding RNA generation. These discoveries provide evidence that xrRNA-based RNA maturation pathways may be more widespread than previously anticipated and are involved in producing a variety of RNAs of diverse function.

RESULTS AND DISCUSSION

To search for new xrRNAD-like elements, we used the Infernal software (S. R. Eddy laboratory), which enables screening of massive data sets of DNA sequences for conserved RNA secondary structure patterns with poor sequence conservation (27). Because the Dianthovirus genus has only three members (Red clover necrotic mosaic virus [RCNMV], Sweet clover necrotic mosaic virus [SCNMV], and Carnation ringspot virus [CRSV]) (26), we expanded our search to other plant-infecting positive-sense RNA viruses. The initial search within a library of viral reference genomes (see Materials and Methods) identified two potential sequences in the Luteoviridae corresponding to the poleroviruses wheat leaf yellowing-associated virus isolate JN-U3 (GenBank accession no. NC_035451; Infernal E value = 0.00025, score = 44.3) and sugarcane yellow leaf virus (GenBank accession no. NC_000874; Infernal E value = 6.5, score = 24.2). With these sequences added to the alignment, subsequent searches identified >40 candidates within the public repository of all available sequences for Tombusviridae and Luteoviridae, demonstrating how powerful this tool is for computationally identifying putative functional elements in viral RNAs (28).

A close inspection of all putative xrRNAD-like elements revealed that their predicted secondary structures contain the same elements as were found in the known xrRNAD. Specifically, the assertion of formation of helices P1 and P2 and a predicted pseudoknot is supported by covariation data, which reveal little sequence conservation (R-scape [29] E values for the 12 covarying base pairs in the stems and the pseudoknot are within 3.10−4 to 8.10−13 (95th percentile = 1.10−12); Fig. 2A). Notably, our search criteria did not contain the pseudoknot interaction; thus, the fact that all putative xrRNAD sequences have the ability to form this functionally important element serves as internal cross-validation. L1 and L2B are >97% conserved in sequence, consistent with their role in creating a specific folded motif that promotes pseudoknot formation (26). Also, two of the three nucleotides immediately upstream of the 3′ side of the pseudoknot are >97% conserved, but their role is not obvious from the crystal structure of the open state. Likewise, the non-Watson-Crick A8-G33 base pair identified in the crystal structure (Fig. 1) cannot be reconciled with the predominant presence of G at position 8 and G/A at position 33 in all the other sequences. These observations support the previous assertion that the crystallized open state represents a folding intermediate of xrRNAD and that structural adjustments and additional interactions are present in the “closed” pseudoknot state.

FIG 2.

FIG 2

Widespread occurrence of Xrn1-resistant RNAs among plant viruses. (A) Consensus sequence and secondary structure of xrRNAD based on a comparative sequence alignment of 47 sequences of viruses belonging to the Tombusviridae and Luteoviridae families (shown in Fig. S1 in the supplemental material). Y = pyrimidine; R = purine. Non-Watson-Crick base pairs are shown using the Leontis-Westhof nomenclature (49). The numbering is that of the crystal structure of the SCNMV xrRNA (26). (B) Phylogenetic relationship between various plant viruses, based on the RNA-dependent RNA polymerase amino acid sequence (31). The viruses and corresponding genera in which we identified xrRNAD structures are marked by a star. Numbers at the nodes refer to bootstrap values as percentages obtained from 2,000 replications, shown only for branches supported by more than 40% of the data. Branch lengths are proportional to the number of changes. Further analysis will likely reveal xrRNAD elements in more of these viruses with additional sequence and structural variation.

FIG S1

Sequence alignment of computationally identified viruses comprising a Dianthovirus-like xrRNA (Stockholm format). Download FIG S1, TIF file, 12.6 MB (12.9MB, tif) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Viruses in which we found putative novel xrRNAs include members of the Tombusviridae and Luteoviridae families. In the Tombusviridae, xrRNAs were found in the Machlomovirus and Umbravirus genera. In the Luteoviridae family, members of the Polerovirus and Enamovirus genera contain putative xrRNAs. We did not find putative xrRNAs in the Luteovirus genus despite its close relationship to the Dianthovirus or in the Sobemovirus genus, which is closely related to Polerovirus. It is possible that these viruses do not have xrRNAs or that they may have xrRNAs that are more divergent in sequence and secondary structure and thus would not be identified with our search criteria. We chose to remain conservative with respect to this search; future work may identify new elements in these viruses as well.

To experimentally determine if the computationally identified elements were authentic xrRNAs, we tested representative sequences from viruses of both families using our established in vitro Xrn1 resistance assay (11). Specifically, in vitro-transcribed and purified RNA sequences from opium poppy mosaic virus (OPMV), Maize chlorotic mottle virus (MCMV), Potato leafroll virus (PLRV), Maize yellow dwarf virus-RMV (MYDV-RMV), and Hubei polero-like virus 1 (HuPLV1) were challenged with recombinant Xrn1. All RNAs stopped Xrn1 degradation similarly to positive-control RCNMV xrRNAD (Fig. 3A and B), demonstrating that they are authentic xrRNAs that do not require additional trans-acting proteins for function. Moreover, mutations to disrupt the putative pseudoknot in the MCMV, PLRV, and HuPLV1 xrRNAs abolished Xrn1 resistance, while compensatory mutations that restore pseudoknot base pairing rescued the activity (Fig. 3C to E), verifying the functional importance of the pseudoknot in all of these examples. In addition, the mapped Xrn1 stop site is at the base of P1 in all newly identified xrRNAs, matching the xrRNAD stop site (Fig. 3F to H; see also Fig. S2 in the supplemental material) (26). Overall, the conserved secondary structure (Fig. 2A), the location of the exoribonuclease stop site, and the strict dependence on the pseudoknot for Xrn1 resistance suggest that these newly identified and tested xrRNAs use molecular folds and mechanisms similar to those seen with xrRNAD. By extension, the same is very likely true of the larger set that we computationally identified; thus, we classify them as members of the xrRNAD class of exonuclease-resistant RNA structures.

FIG 3.

FIG 3

Biochemical characterization of representative plant virus xrRNAD elements. (A) In vitro Xrn1 resistance assay of xrRNAD from various plant RNA viruses (Table 1). The xrRNA from RCNMV was included as a positive control. Arrows indicate the size of full-length RNAs and Xrn1-resistant degradation products. (B) Classification of viruses used in the experiments represented in panel A (Table 1). (C to E) In vitro Xrn1 resistance assay of wild-type (WT) and pseudoknot (PK) mutant versions of MCMV (C), PLRV (D), and HuPLV1 (E) xrRNAs. (F to H) Reverse transcription (RT) mapping of the Xrn1 stop site. Data represent distributions of RT products of Xrn1-resistant fragments of MCMV (F), PLRV (G), and HuPLV1 (H) degradation fragments. Experimentally validated stop sites are indicated on the secondary structure diagrams for all tested xrRNAD shown in Fig. S2.

FIG S2

Predicted secondary structure diagrams for biochemically tested xrRNAD. Results of RT mapping of Xrn1 halt sites are shown for OPMV and MYDV-RMV. RCNMV data are from a previously published article (A. L. Steckelberg, B. M. Akiyama, D. A. Costantino, T. L. Sit, et al., PNAS 115:6404–6409, 2018). Download FIG S2, JPG file, 0.3 MB (334.3KB, jpg) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Although the newly identified xrRNAD elements share many features, there are notable structural differences in a subset of xrRNAs found in the Tombusviridae family (RCNMV, SCNMV, CRSV, OPMV, and MCMV). Specifically, these xrRNAD have a P3 stem-loop immediately downstream of the pseudoknot (Fig. 2A) (Table 1; see also Table S1 in the supplemental material). Although the presence of P3 was not recognized in the previous characterization of dianthovirus xrRNAs, the truncation analysis in that study showed that this part of the sequence is not required by xrRNAD for Xrn1 resistance in vitro (26). Consistent with this, an analogous stem-loop (P4) found in xrRNAF1 is also dispensable in vitro; the crystal structure indicates that it may stabilize the pseudoknot through stacking interactions (Fig. 1) (24). Therefore, in xrRNAD, coaxial stacking of P3 on P1/P2 could similarly stabilize the RNA structure in the cell during infection, but it is not necessary in all contexts.

TABLE 1.

Selected set of plant viruses possessing an xrRNADa

Name Abbreviation Classification GenBank
accession no.
Length
(nt)
Genomic
location (nt)b
Genomic context
Red clover necrotic mosaic virus RCNMV Tombusviridae;
Dianthovirus
NC_003756 3,890 3461–3504 3′ UTR
Sweet clover necrotic mosaic virus SCNMV Tombusviridae;
Dianthovirus
NC_003806 3,876 3446–3489 3′ UTR
Maize chlorotic mottle virus
(isolate KS1)
MCMV Tombusviridae;
Machlomovirus
NC_003627 4,437 4101–4143 3′ UTR
Opium poppy mosaic virus
(isolate PHEL5235)
OPMV Tombusviridae;
Umbravirus
NC_027710 4,230 3585–3629 3′ UTR
Carrot mottle mimic umbravirus CMoMV Tombusviridae;
Umbravirus
NC_001726 4,201 2664–2706 74 nt to AUG from ORF3
Chickpea chlorotic stunt virus CpCSV Luteoviridae; Polerovirus NC_008249 5,900 3489–3534 11 nt to AUA from ORF3a;
129 nt to AUG from ORF3–5
Cowpea polerovirus 1
(isolate BE167)
CpPV1 Luteoviridae; Polerovirus NC_034246 5,845 3380–3425 11 nt to CUG from ORF3a;
129 nt to AUG from ORF3–5
Cotton leafroll dwarf virus CoLRDV Luteoviridae; Polerovirus NC_014545 5,866 3451–3499 13 nt to CUG from ORF3a;
131 nt to AUG from ORF3–5
Cereal yellow dwarf virus-RPV CYDV-RPV Luteoviridae; Polerovirus NC_004751 5,723 3566–3622 14 nt to AUU from ORF3a;
132 nt to AUG from ORF3–5
Maize yellow dwarf virus-RMV
(formerly BYDV)
MYDV-RMV Luteoviridae; Polerovirus NC_021484 5,612 3335–3384 14 nt to ACG from ORF3a;
132 nt to AUG from ORF3–5
Potato leafroll virus PLRV Luteoviridae; Polerovirus NC_001747 5,987 3509–3557 18 nt to AUA from ORF3a;
136 nt to AUG from ORF3–5
Sugarcane yellow leaf virus ScYLV Luteoviridae; Polerovirus NC_000874 5,899 3467–3512 18 nt to CUG from ORF3a;
136 nt to AUG from ORF3–5
Beet Western yellows virus BWYV Luteoviridae; Polerovirus NC_004756 5,666 3346–3393 Defective ORF3a; 138 nt
to AUG from ORF3–5
Beet Western yellows luteovirus
(strain bwyv-1, isolate 28a)
BWYV Luteoviridae; Polerovirus L39983 973 341–389 135 nt to AUG from ORF3–5
Hubei polero-like virus 2
(strain QTM26674)
HuPLV2 Unclassified NC_033229 6,083 3706–3753 133 nt to AUG from ORF3–5
Hubei polero-like virus 1
(strain WHCC118254)
HuPLV1 Unclassified NC_032224 4,213 3357–3410 135 nt to AUG from ORF3–5
a

Viruses are grouped by the genomic context of the xrRNA (last column). The complete list of sequences used for comparative sequence alignment is shown in Table S1. Smirnova et al. (30) was used as a reference for updated annotations of ORF3a. BYDV, Barley yellow dwarf virus; nt, nucleotide(s).

b

xrRNA boundaries are defined as the first nucleotide of the P1 stem and the last nucleotide of the pseudoknot.

TABLE S1

Complete list of computationally identified viruses comprising a Dianthovirus-like xrRNA. Download Table S1, PDF file, 1.2 MB (1.2MB, pdf) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

All previously known xrRNAs lie upstream of noncoding RNAs and lead to the generation of sgRNAs that do not encode proteins; however, the location of the newly discovered xrRNAs reveals unexpected variation and thus potential new roles for xrRNAs in general (Fig. 4). Surprisingly, only two of the newly identified xrRNAs are in the 3′UTR of the viral genome (Table 1). In MCMV, the first nucleotide of the P1 helix matches the 5′ end of noncoding sgRNA2 (30); thus, as with the dianthoviruses, flaviviruses, and other xrRNAs, this new element probably blocks Xrn1 to generate noncoding sgRNAs derived from the 3′UTR. In contrast, for some members of the Tombusviridae family as well as for poleroviruses, xrRNAD is located in an intergenic region 5 to 20 nucleotides upstream from the translation start site of open reading frame 3a (ORF3a) and ∼135 nucleotides from the start site of a readthrough protein encoded by ORF3 to ORF5 (ORF3–5) (our data suggest that ORF3a has not been annotated for all poleroviruses; see Table S1). ORF3a codes for protein P3a, which is essential for long-distance movement of the virus in plants (30). Translation of ORF3a initiates from sgRNA1 at a non-AUG codon (Table 1; see also Table S1) (3032). The location of the xrRNAD upstream of the ORF3a start site implies that these xrRNAs, rather than functioning in noncoding RNA production, might act to produce or maintain protein-coding RNAs (Fig. 4).

FIG 4.

FIG 4

xrRNAD can produce or protect both coding and noncoding sgRNAs. The presence of xrRNAD in different contexts suggests an expanded role for these RNA elements. Full-length viral genomic RNA (top; colored boxes symbolize ORFs) can be processed by exoribonucleases that stop at xrRNAs (depicted as dashed structures) to yield both protein-coding sgRNAs (middle) and noncoding sgRNAs (bottom). Also, sgRNAs produced by subgenomic promoters could be “trimmed” or protected by xrRNAs (not shown). Only some umbraviruses (e.g., OPMV) possess two xrRNAD elements. Note that the ORF organization characteristics are not identical in all of these viruses; thus, this depiction should be considered conceptual. Details of the genetic organization and xrRNA location can be found in Fig. S3.

FIG S3

Variable genomic location of xrRNAD among plant viruses. (Left) Schematic genomic organization of plant virus genera that harbor xrRNAD elements. xrRNAD are depicted as red hexagons. Genomes are drawn to scale. (Right) sgRNAs or putative sgRNAs that would arise through incomplete degradation of the viral genome by 5´-to-3´ exoribonucleases. Note that the 5´ end of a sgRNA coincides with the 5´ end of xrRNAD for Dianthovirus and Machlomovirus; the mapped 5´ ends of sgRNAs are slightly upstream of the xrRNAD (indicated by dashed line) for Polerovirus and Umbravirus, suggesting that additional trimming events might be involved in sgRNA production. The asterisk indicates a second xrRNAD element that was bioinformatically identified in OPMV but has not been tested biochemically. All other xrRNAD elements depicted here have been biochemically verified in vitro. Download FIG S3, JPG file, 0.5 MB (563.4KB, jpg) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The presence of xrRNAD in intergenic regions and upstream of protein-coding sequences suggests several possibilities for the role of xrRNAs in this new context. First, these intergenic xrRNAD could be used to produce sgRNAs similarly to the role ascribed to xrRNAs in 3′UTRs; that is, sgRNAs could be produced by incomplete degradation of full-length genomic RNAs without requiring a subgenomic promoter. Alternatively, precursor sgRNAs could be produced by transcription from a subgenomic promoter or from templates made by premature termination during negative-strand synthesis. These precursor RNAs could be subsequently “trimmed” by exonucleases to yield a mature sgRNA. In this scenario, the transcription start site could be at any distance from the 5′ end of the mature sgRNA. Another possibility is that the sgRNA could be produced by transcription from a subgenomic promoter and that the role of the xrRNA would be to protect sgRNA from 5′-to-3′ degradation by cellular exoribonucleases. Our data suggest that all of the scenarios are possible and that the roles of intergenic xrRNAD may be different in different viruses. For example, unlike in MCMV, the 5′ end of the xrRNAD sequence in PLRV (Luteoviridae; Polerovirus) does not correspond to the mapped 5′ end of the sgRNA1. Rather, it is located 28 nucleotides upstream of the proposed exoribonuclease stop site. Furthermore, previous studies showed that PLRV sgRNA1 is likely generated by a replicative mechanism and thus that the xrRNA in PLRV probably does not directly function in the initial generation of sgRNA1 (33). This organization is also found in beet Western yellows virus (also a polerovirus) (34). In this case, the xrRNAD might be involved in a regulatory “trimming” step that alters the 5′ end of existing transcripts, a process that may therefore occur only under certain conditions or at certain times in viral infection. Before testing this hypothesis, it would be crucial to determine if, when, and where xrRNA-dependent sgRNAs accumulate in infected cells and if there is variation in the 5′ end within the population of a specific sgRNA. Moreover, mapping precise 5′ ends of additional sgRNAs from different virus species (and comparing them to the location of xrRNAD) is needed to provide insight into the potential functions of xrRNAs during the generation, maintenance, and regulation of viral coding and noncoding sgRNAs.

That xrRNAD are at or near the 5′ end of protein coding sgRNAs raises the issue of whether or not sgRNAs produced or maintained by intergenic xrRNAD can be translated. The 5′ end of sgRNAs resulting from xrRNA-dependent halting of 5′-to-3′ degradation would not have a modified nucleotide 5′ “cap”; thus, sgRNAs lack the canonical translation initiation signal. However, since viruses of the Tombusviridae family use 3′-proximal cap-independent translation enhancers (3′-CITEs) to initiate translation, uncapped sgRNAs with xrRNAs on their 5′ ends could potentially be translationally active (35, 36). In addition, it has been shown that some of these viruses use diverse 3′-CITEs and different amounts of various sgRNA species to fine-tune viral protein production during infection. Thus, these xrRNAs could be part of a larger RNA structure-dependent mechanism involving 3′-CITEs and xrRNAs in regulation of both the amount and translational activity of protein-encoding viral genomic RNAs and sgRNAs (37). Again, the details of such mechanisms would almost certainly differ in various viral species.

In contrast to the members of the Tombusviridae family, not all Luteoviridae members contain 3′CITEs; thus, if xrRNAD-associated sgRNAs are translated, they must use a different mechanism of translation initiation. For example, in the Polerovirus genus, cap-independent translation is likely conferred by genome-linked proteins (VPg) that are covalently attached to the 5′ end of the viral genome (W. Allen Miller, personal communication). The related sobemoviruses also have a VPg attached to their sgRNAs (3841), but whether this is also true of polerovirus sgRNAs is currently unknown. Any sgRNAs resulting from xrRNAD-dependent exoribonuclease resistance would be expected to have a 5′ monophosphate and not a VPg, raising the possibilities that such sgRNAs would be translationally inactive but could be maintained for some regulatory purpose and that there could be pools of translationally active and inactive sgRNAs. These possibilities all remain speculative; understanding the purpose of xrRNAD in each virus, how they relate to translation, and the existence of any larger trends will require ongoing detailed studies of diverse viruses.

Overall, our discoveries suggest that the roles of xrRNAs are more diverse than previously realized, depending on their genetic context. The presence of xrRNAs in various locations within viral genomes suggests that new xrRNA scaffolds may emerge from analyzing sgRNA 5′ termini from other viruses; certainly, not all xrRNA elements were identified by the algorithm used here (5, 7, 42). Intriguing candidates for novel xrRNA identification include viruses with no obvious upstream promoter elements for sgRNA production and viruses in which putative promoter sequences do not seem to correspond well to the sgRNA 5′ end (1, 5, 42, 43).

Many issues remain that pertain to understanding the structural/sequence requirements for Xrn1 resistance, the degree to which structural variation is tolerated, and how sequence diversity is integrated into similar folds (44). The now-expanded set of xrRNAD candidates provides a broader phylogeny for future bioinformatic and structural studies that will address these points.

MATERIALS AND METHODS

Computational search.

The published alignment performed with sequences from a total of three virus species (RCNMV, SCNMV, and CRSV) (26) was manually expanded in Ugene v. 1.29.0 (45) with two RCNMV variants (GenBank accession no. J04357 and AB034916) retrieved from a standard nucleotide BLAST search for “somewhat dissimilar sequences” (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch). Sequences were aligned to the conserved 3D-based secondary structure, omitting the pseudoknot, and were exported in Stockholm format (see Fig. S4A in the supplemental material).

FIG S4

Alignments. Download FIG S4, PDF file, 0.3 MB (282.8KB, pdf) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Using Infernal v. 1.1.2 (27) with default parameters, we searched for domains with similar structures and sequences within the complete reference genomes of viruses available from RefSeq, the NCBI Reference Sequence Database (https://www.ncbi.nlm.nih.gov/refseq/; downloaded on 10 January 2018). For subsequent iterations with Infernal, we searched the complete database of Tombusviridae and Luteoviridae available at GenBank (downloaded on 3 July 2018), using the alignment shown in Fig. S4B in the supplemental material.

In Ugene, we systematically added new hits from Infernal to the alignment only when they met the following criteria: (i) the sequence showed variation in more than 3 to 5 locations from the sequences already in the alignment; (ii) the Infernal E value was <0.05; (iii) the Infernal score was >10; (iv) the genomic context was coherent with that of the sequences already in the alignment. But a key objective in expanding the alignment further was also to analyze potential hits with a higher E value/a lower score, as they would often correspond to positive hits but with a larger sequence or structure variation. By the time the alignment reached a size of 10 to 12 sequences, we were able to retrieve most of the sequences that made it into the final alignment through further iterations of Infernal searches and manual addition to the alignment. Hits for unclassified viruses were also retrieved from large-scale transcriptomics data of invertebrate and vertebrate-associated RNA viruses using the deposited sequences (46, 47).

A statistical validation of the final proposed alignment of 47 sequences was performed using the latest version of R-scape available at http://eddylab.org/R-scape/ (29) (last accessed on 17 August 2018). The corresponding conserved structure and sequence patterns were rendered using R2R v. 1.0.5 (48).

Design of RNAs for in vitro assays.

The DNA templates used for in vitro transcription were gBlocks ordered from IDT and were cloned into pUC19 and verified by sequencing. RNA constructs for Xrn1 degradation assays contained the xrRNA sequence plus ∼30 nucleotides of the endogenous upstream sequence (“leader sequence”) to allow loading of the exoribonucleases. Table 2 shows the sequences used in in vitro Xrn1 degradation assays.

TABLE 2.

Sequences used in the in vitro Xrn1 degradation assaysa

RNA Sequence (5′–3′)
OPMV xrRNA TAATACGACTCACTATAGGAATTGCCTCCACCAGTAACTAAACCCAACCACAGCCAAGCATTAAGTTGCAAGCGTTGGAGTGGCAGGCTT
AACGTCCGACAGTACGACAACTGCGG
MCMV xrRNA TAATACGACTCACTATAGGTTCCAGGCCCAGGGCTGGCAAATCATTGAGCACAAGGTGAGCCGGCATGAGGTTGCAAGACCGGAACAACC
AGTCCTTCTGGCAGAGTCCTGCCAA
PLRV xrRNA TAATACGACTCACTATAgGCCACCACAAAAGAACACTGAAGGAGCTCACTAAAACTAGCCAAGCATACACGAGTTGCAAGCATTGGAAGT
TCAAGCCTCGT
MYDV-RMV
xrRNA
TAATACGACTCACTATAgGTCCAGAAACAAAAAGTTTAAAACAGAAGCTCTCAAGTCAGCCAGGCAAATTCGAGTTGCAAGCACTGGATG
ACCTAGTCTCGATA
HuPLV1 xrRNA TAATACGACTCACTATAgGCCACAAAACGAATAAAGGAAGAACGCACGAGAGTCAGCCAAACAAACACAAGTTGCAAGTGTTGGAGACT
CATTCTAGTCTTGT
a

The T7 promoter sequences are underlined, the leader sequence are indicated in italics, and the first protected nucleotides (experimentally validated as described here) are indicated in bold. Lowercase letters indicate extra nucleotides inserted to allow better transcription.

RNA preparation.

DNA templates for in vitro transcription were amplified by PCR using custom DNA primers (IDT) and Phusion Hot Start polymerase (New England BioLabs). Transcription reaction mixtures (2.5 ml) were assembled using 1,000-µl PCR reaction mixtures as the template (∼0.2 µM template DNA, a 6 mM concentration of each NTP, 60 mM MgCl2, 30 mM Tris [pH 8.0], 10 mM dithiothreitol [DTT], 0.1% spermidine, 0.1% Triton X-100, T7 RNA polymerase, and 2 µl RNasin RNase inhibitor [Promega]) and incubated overnight at 37°C. After inorganic pyrophosphates were precipitated by centrifugation, the reaction mixtures were ethanol precipitated and purified on a 7 M urea–8% denaturing polyacrylamide gel. RNAs of the correct size were excised, eluted overnight at 4°C into ∼40 ml of diethylpyrocarbonate (DEPC)-treated Milli-Q filtered water (Millipore), and concentrated using Amicon Ultra spin concentrators (Millipore). Mutations were introduced using mutagenized custom DNA reverse primers (Table 3).

TABLE 3.

Primers used in this studya

Primer Sequence (5′–3′)
OPMV_WT_rev 5′-CCGCAGTTGTCGTACTGTCGG-3′
OPMV_PKmut1_rev 5′-CCGCAGTTGTCGTACTGTCGGACGAATTGCCTGCCACTCCAACGC-3′
OPMV_PKmut2_rev 5′-CCGCAGTTGTCGTACTGTCGGACGTTAAGCCTGCCACTCCAACGCTTGCAACAATTTGCTT GGCTGTGGTTGG-3′
OPMV_PKcomp_rev 5′-CCGCAGTTGTCGTACTGTCGGACGAATTGCCTGCCACTCCAACGCTTGCAACAATTTGCTT GGCT GTGGTTGG-3′
MCMV_WT_rev 5′-TGGCAGGACTCTGCCAGAAGG-3′
MCMV_PKmut1_rev 5′-TGGCAGGACTCTGCCAGCTCCACTGGTTGTTCCGGTCTTGC-3′
MCMV_PKmut2_rev 5′-TGGCAGGACTCTGCCAGAAGGACTGGTTGTTCCGGTCTTGCAAGGAGATGCCGGCTCACC TTGTGCTC-3′
MCMV_PKcomp_rev 5′-TGGCAGGACTCTGCCAGCTCCACTGGTTGTTCCGGTCTTGCAAGGAGATGCCGGCTCACC TTGTGCTC-3′
PLRV_WT_rev 5′-ACGAGGCTTGAACTTCCAATGC-3′
PLRV_PKmut1_rev 5′-TGCTGGCTTGAACTTCCAATGCTTGC-3′
PLRV_PKmut2_rev 5′-ACGAGGCTTGAACTTCCAATGCTTGCAACAGCAGTATGCTTGGCTAGTTTTAGTG-3′
PLRV_PKcomp_rev 5′-TGCTGGCTTGAACTTCCAATGCTTGCAACAGCAGTATGCTTGGCTAGTTTTAGTG-3′
MYDV-RMV_WT_rev 5′-TATCGAGACTAGGTCATCCAGTGC-3′
huPLV_WT_rev 5′-ACAAGACTAGAATGAGTCTCC-3′
huPLV_PKmut1_rev 5′-TGTTGACTAGAATGAGTCTCCAACACTTGC-3′
huPLV_PKmut2_rev 5′-ACAAGACTAGAATGAGTCTCCAACACTTGCAACAACAGTTTGTTTGGCTGACTCTCG-3′
huPLV_PKcomp_rev 5′-TGTTGACTAGAATGAGTCTCCAACACTTGCAACAACAGTTTGTTTGGCTGACTCTCG-3′
a

Mutated residues are indicated in bold.

In vitro Xrn1 resistance assays.

RNA (4 µg) was resuspended in 40 µl 100 mM NaCl–10 mM MgCl2–50 mM Tris (pH 7.5)–1 mM DTT and refolded at 90°C for 3 min and then at 20°C for 5 min. A 3-µl volume of recombinant RppH (0.5 µg/µl stock) was added, and the samples were split into two 20-µl reaction mixtures (with or without exoribonuclease). A 1-µl volume of the recombinant Xrn1 (0.8 µg/µl stock) was added where indicated. All reaction mixtures were incubated for 2 h at 30°C using a thermocycler. The degradation reaction mixtures were resolved on a 7 M urea–8% denaturing polyacrylamide gel and stained with ethidium bromide.

Mapping of the exoribonuclease stop site.

To determine the Xrn1 stop site at single-nucleotide resolution, 30 µg in vitro-transcribed RNA was degraded using recombinant RppH and Xrn1 as described above (the reaction volume was scaled up to 300 µl, and 20 µl of each enzyme was used). The degradation reaction mixture was resolved on a 7 M urea–8% polyacrylamide gel, and then the Xrn1-resistant degradation product was cut from the gel and eluted overnight at 4°C into ∼20 ml of diethylpyrocarbonate (DEPC)-treated Milli-Q filtered water (Millipore) and concentrated using Amicon Ultra spin concentrators (Millipore). Once recovered, the RNA was subjected to reverse transcription (RT) using Superscript III reverse transcriptase (Thermo) and a 6-carboxyfluorescein (FAM) (6-fluorescein amidite)-labeled sequence-specific reverse primer (IDT) with a 20 (A) stretch at the 5′ end to allow cDNA purification with oligo(dT) beads. The RT reaction volumes (5 µl) contained 1.2 pM RNA, 0.25 µl 0.25 µM FAM-labeled reverse primer, 1 µl 5× first-strand buffer, 0.25 µl 0.1 M DTT, 0.4 µl 10 mM deoxynucleoside triphosphate (dNTP) mix, and 0.1 µl Superscript III reverse transcriptase (200 U/µl) and were incubated for 1 h at 50°C. To hydrolyze the RNA template after reverse transcription, 5 µl of 0.4 M NaOH was added and the reaction mixture incubated at 90°C for 3 min, followed by cooling on ice for 3 min. The reaction was neutralized by adding 5 µl of acid quench mix (1.4 M NaCl, 0.57 M HCl, 1.3 M sodium acetate, pH 5.2), and then 1.5 µl of oligo(dT) beads [Poly(A)Purist MAG kit (Thermo)] was added and the cDNA was purified on a magnetic stand according to the manufacturer’s instructions. The cDNA was eluted in 11 µl ROX-HiDi and analyzed on a model 3500 Genetic Analyzer (Applied Biosystems) for capillary electrophoresis. A Sanger sequencing (ddNTP) ladder of the undigested RNA was analyzed alongside each degradation product as a reference for band annotation.

Data availability.

All data are available from us.

ACKNOWLEDGMENTS

We gratefully acknowledge David Farrell for information technology (IT) support; the members of the laboratory of J.S.K. for useful discussions; and David Costantino for careful reading of the manuscript.

This work was supported by NIH grants R35GM118070 and R01AI133348 (J.S.K.) and DFG STE 2509/2-1 (A.-L.S.). We declare that we have no conflicts of interest. A.-L.S., Q.V., and J.S.K. designed and analyzed the research; Q.V. performed the computational search; A.-L.S. performed the biochemical experiments; A.-L.S., Q.V., and J.S.K. wrote the paper.

Footnotes

Citation Steckelberg A-L, Vicens Q, Kieft JS. 2018. Exoribonuclease-resistant RNAs exist within both coding and noncoding subgenomic RNAs. mBio 9:e02461-18. https://doi.org/10.1128/mBio.02461-18.

Contributor Information

Alexander Idnurm, University of Melbourne.

Samuel Butcher, UW-Madison.

W. Allen Miller, Iowa State University.

REFERENCES

  • 1.Miller WA, Shen R, Staplin W, Kanodia P. 2016. Noncoding RNAs of plant viruses and viroids: sponges of host translation and RNA interference machinery. Mol Plant Microbe Interact 29:156–164. doi: 10.1094/MPMI-10-15-0226-FI. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sztuba-Solińska J, Stollar V, Bujarski JJ. 2011. Subgenomic messenger RNAs: mastering regulation of (+)-strand RNA virus life cycle. Virology 412:245–255. doi: 10.1016/j.virol.2011.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Miller WA, Koev G. 2000. Synthesis of subgenomic RNAs by positive-strand RNA viruses. Virology 273:1–8. doi: 10.1006/viro.2000.0421. [DOI] [PubMed] [Google Scholar]
  • 4.Jiwan SD, White KA. 2011. Subgenomic mRNA transcription in Tombusviridae. RNA Biol 8:287–294. doi: 10.4161/rna.8.2.15195. [DOI] [PubMed] [Google Scholar]
  • 5.Koev G, Miller WA. 2000. A positive-strand RNA virus with three very different subgenomic RNA promoters. J Virol 74:5988–5996. doi: 10.1128/JVI.74.13.5988-5996.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Shen R, Miller WA. 2004. Subgenomic RNA as a riboregulator: negative regulation of RNA replication by Barley yellow dwarf virus subgenomic RNA 2. Virology 327:196–205. doi: 10.1016/j.virol.2004.06.025. [DOI] [PubMed] [Google Scholar]
  • 7.Flobinus A, Chevigny N, Charley PA, Seissler T, Klein E, Bleykasten-Grosshans C, Ratti C, Bouzoubaa S, Wilusz J, Gilmer D. 2018. Beet necrotic yellow vein virus noncoding RNA production depends on a 5'–>3' Xrn exoribonuclease activity. Viruses 10:137. doi: 10.3390/v10030137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pijlman GP, Funk A, Kondratieva N, Leung J, Torres S, van der Aa L, Liu WJ, Palmenberg AC, Shi PY, Hall RA, Khromykh AA. 2008. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 4:579–591. doi: 10.1016/j.chom.2008.10.007. [DOI] [PubMed] [Google Scholar]
  • 9.Roby JA, Pijlman GP, Wilusz J, Khromykh AA. 2014. Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses. Viruses 6:404–427. doi: 10.3390/v6020404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Iwakawa HO, Mizumoto H, Nagano H, Imoto Y, Takigawa K, Sarawaneeyaruk S, Kaido M, Mise K, Okuno T. 2008. A viral noncoding RNA generated by cis-element-mediated protection against 5'->3' RNA decay represses both cap-independent and cap-dependent translation. J Virol 82:10162–10174. doi: 10.1128/JVI.01027-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chapman EG, Moon SL, Wilusz J, Kieft JS. 2014. RNA structures that resist degradation by Xrn1 produce a pathogenic dengue virus RNA. Elife 3:e01892. doi: 10.7554/eLife.01892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Moon SL, Anderson JR, Kumagai Y, Wilusz CJ, Akira S, Khromykh AA, Wilusz J. 2012. A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA 18:2029–2040. doi: 10.1261/rna.034330.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Charley PA, Wilusz CJ, Wilusz J. 2018. Identification of phlebovirus and arenavirus RNA sequences that stall and repress the exoribonuclease XRN1. J Biol Chem 293:285–295. doi: 10.1074/jbc.M117.805796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Clarke BD, Roby JA, Slonchak A, Khromykh AA. 2015. Functional non-coding RNAs derived from the flavivirus 3' untranslated region. Virus Res 206:53–61. doi: 10.1016/j.virusres.2015.01.026. [DOI] [PubMed] [Google Scholar]
  • 15.Schnettler E, Tykalova H, Watson M, Sharma M, Sterken MG, Obbard DJ, Lewis SH, McFarlane M, Bell-Sakyi L, Barry G, Weisheit S, Best SM, Kuhn RJ, Pijlman GP, Chase-Topping ME, Gould EA, Grubhoffer L, Fazakerley JK, Kohl A. 2014. Induction and suppression of tick cell antiviral RNAi responses by tick-borne flaviviruses. Nucleic Acids Res 42:9436–9446. doi: 10.1093/nar/gku657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schnettler E, Sterken MG, Leung JY, Metz SW, Geertsema C, Goldbach RW, Vlak JM, Kohl A, Khromykh AA, Pijlman GP. 2012. Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and mammalian cells. J Virol 86:13486–13500. doi: 10.1128/JVI.01104-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Göertz GP, Fros JJ, Miesen P, Vogels CB, van der Bent ML, Geertsema C, Koenraadt CJ, van Rij RP, van Oers MM, Pijlman GP. 2016. Noncoding subgenomic flavivirus RNA is processed by the mosquito RNA interference machinery and determines West Nile virus transmission by Culex pipiens mosquitoes. J Virol 90:10145–10159. doi: 10.1128/JVI.00930-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Schuessler A, Funk A, Lazear HM, Cooper DA, Torres S, Daffis S, Jha BK, Kumagai Y, Takeuchi O, Hertzog P, Silverman R, Akira S, Barton DJ, Diamond MS, Khromykh AA. 2012. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. J Virol 86:5708–5718. doi: 10.1128/JVI.00207-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bidet K, Dadlani D, Garcia-Blanco MA. 2014. G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog 10:e1004242. doi: 10.1371/journal.ppat.1004242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu Y, Liu H, Zou J, Zhang B, Yuan Z. 2014. Dengue virus subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway. Virology 448:15–25. doi: 10.1016/j.virol.2013.09.016. [DOI] [PubMed] [Google Scholar]
  • 21.Manokaran G, Finol E, Wang C, Gunaratne J, Bahl J, Ong EZ, Tan HC, Sessions OM, Ward AM, Gubler DJ, Harris E, Garcia-Blanco MA, Ooi EE. 2015. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350:217–221. doi: 10.1126/science.aab3369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Funk A, Truong K, Nagasaki T, Torres S, Floden N, Balmori Melian E, Edmonds J, Dong H, Shi PY, Khromykh AA. 2010. RNA structures required for production of subgenomic flavivirus RNA. J Virol 84:11407–11417. doi: 10.1128/JVI.01159-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.MacFadden A, O'Donoghue Z, Silva P, Chapman EG, Olsthoorn RC, Sterken MG, Pijlman GP, Bredenbeek PJ, Kieft JS. 2018. Mechanism and structural diversity of exoribonuclease-resistant RNA structures in flaviviral RNAs. Nat Commun 9:119. doi: 10.1038/s41467-017-02604-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Akiyama BM, Laurence HM, Massey AR, Costantino DA, Xie X, Yang Y, Shi PY, Nix JC, Beckham JD, Kieft JS. 2016. Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease. Science 354:1148–1152. doi: 10.1126/science.aah3963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chapman EG, Costantino DA, Rabe JL, Moon SL, Wilusz J, Nix JC, Kieft JS. 2014. The structural basis of pathogenic subgenomic flavivirus RNA (sfRNA) production. Science 344:307–310. doi: 10.1126/science.1250897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Steckelberg AL, Akiyama BM, Costantino DA, Sit TL, Nix JC, Kieft JS. 2018. A folded viral noncoding RNA blocks host cell exoribonucleases through a conformationally dynamic RNA structure. Proc Natl Acad Sci U S A 115:6404–6409. doi: 10.1073/pnas.1802429115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nawrocki EP, Eddy SR. 2013. Computational identification of functional RNA homologs in metagenomic data. RNA Biol 10:1170–1179. doi: 10.4161/rna.25038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lim CS, Brown CM. 2017. Know your enemy: successful bioinformatic approaches to predict functional RNA structures in viral RNAs. Front Microbiol 8:2582. doi: 10.3389/fmicb.2017.02582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rivas E, Clements J, Eddy SR. 2017. A statistical test for conserved RNA structure shows lack of evidence for structure in lncRNAs. Nat Methods 14:45–48. doi: 10.1038/nmeth.4066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Smirnova E, Firth AE, Miller WA, Scheidecker D, Brault V, Reinbold C, Rakotondrafara AM, Chung BY, Ziegler-Graff V. 2015. Discovery of a small non-AUG-initiated ORF in poleroviruses and luteoviruses that is required for long-distance movement. PLoS Pathog 11:e1004868. doi: 10.1371/journal.ppat.1004868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ryabov EV, Taliansky ME, Robinson DJ, Waterhouse PM, Murant AF, de Zoeten GA, Falk BW, Vetten HJ, Gibbs MJ. 2012. Genus umbravirus, p 1191–1195. In Virus taxonomy: Ninth report of the International Committee on Taxonomy of Viruses. Academic Press, Inc, San Diego, CA. [Google Scholar]
  • 32.Stevens M, Freeman B, Liu HY, Herrbach E, Lemaire O. 2005. Beet poleroviruses: close friends or distant relatives? Mol Plant Pathol 6:1–9. doi: 10.1111/j.1364-3703.2004.00258.x. [DOI] [PubMed] [Google Scholar]
  • 33.Miller JS, Mayo MA. 1991. The location of the 5' end of the potato leafroll luteovirus subgenomic coat protein mRNA. J Gen Virol 72:2633–2638. doi: 10.1099/0022-1317-72-11-2633. [DOI] [PubMed] [Google Scholar]
  • 34.Miller WA, Dinesh-Kumar SP, Paul CP. 1995. Luteovirus gene expression. Crit Rev Plant Sci 14:179–211. doi: 10.1080/07352689509701926. [DOI] [Google Scholar]
  • 35.Miller WA, Jackson J, Feng Y. 2015. cis- And trans-regulation of luteovirus gene expression by the 3' end of the viral genome. Virus Res 206:37–45. doi: 10.1016/j.virusres.2015.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Miller WA, White KA. 2006. Long-distance RNA-RNA interactions in plant virus gene expression and replication. Annu Rev Phytopathol 44:447–467. doi: 10.1146/annurev.phyto.44.070505.143353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Newburn LR, White KA. 2015. Cis-acting RNA elements in positive-strand RNA plant virus genomes. Virology 479–480:434–443. doi: 10.1016/j.virol.2015.02.032. [DOI] [PubMed] [Google Scholar]
  • 38.Ghosh A, Rutgers T, Ke-Qiang M, Kaesberg P. 1981. Characterization of the coat protein mRNA of Southern bean mosaic virus and its relationship to the genomic RNA. J Virol 39:87–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Reinbold C, Lacombe S, Ziegler-Graff V, Scheidecker D, Wiss L, Beuve M, Caranta C, Brault V. 2013. Closely related poleroviruses depend on distinct translation initiation factors to infect Arabidopsis thaliana. Mol Plant Microbe Interact 26:257–265. doi: 10.1094/MPMI-07-12-0174-R. [DOI] [PubMed] [Google Scholar]
  • 40.Hacker DL, Sivakumaran K. 1997. Mapping and expression of Southern bean mosaic virus genomic and subgenomic RNAs. Virology 234:317–327. doi: 10.1006/viro.1997.8667. [DOI] [PubMed] [Google Scholar]
  • 41.Hébrard E, Pinel-Galzi A, Fargette D. 2008. Virulence domain of the RYMV genome-linked viral protein VPg towards rice rymv1-2-mediated resistance. Arch Virol 153:1161–1164. doi: 10.1007/s00705-008-0087-9. [DOI] [PubMed] [Google Scholar]
  • 42.Johnston JC, Rochon DM. 1995. Deletion analysis of the promoter for the cucumber necrosis virus 0.9-kb subgenomic RNA. Virology 214:100–109. doi: 10.1006/viro.1995.9950. [DOI] [PubMed] [Google Scholar]
  • 43.Scheets K. 2000. Maize chlorotic mottle machlomovirus expresses its coat protein from a 1.47-kb subgenomic RNA and makes a 0.34-kb subgenomic RNA. Virology 267:90–101. doi: 10.1006/viro.1999.0107. [DOI] [PubMed] [Google Scholar]
  • 44.Toor N, Keating KS, Taylor SD, Pyle AM. 2008. Crystal structure of a self-spliced group II intron. Science 320:77–82. doi: 10.1126/science.1153803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Okonechnikov K, Golosova O, Fursov M, UGENE team. 2012. Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics 28:1166–1167. doi: 10.1093/bioinformatics/bts091. [DOI] [PubMed] [Google Scholar]
  • 46.Shi M, Lin XD, Chen X, Tian JH, Chen LJ, Li K, Wang W, Eden JS, Shen JJ, Liu L, Holmes EC, Zhang YZ. 2018. The evolutionary history of vertebrate RNA viruses. Nature 556:197–202. doi: 10.1038/s41586-018-0012-7. [DOI] [PubMed] [Google Scholar]
  • 47.Shi M, Lin XD, Tian JH, Chen LJ, Chen X, Li CX, Qin XC, Li J, Cao JP, Eden JS, Buchmann J, Wang W, Xu J, Holmes EC, Zhang YZ. 2016. Redefining the invertebrate RNA virosphere. Nature 540:539–543. doi: 10.1038/nature20167. [DOI] [PubMed] [Google Scholar]
  • 48.Weinberg Z, Breaker RR. 2011. R2R—software to speed the depiction of aesthetic consensus RNA secondary structures. BMC Bioinformatics 12:3. doi: 10.1186/1471-2105-12-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Leontis NB, Westhof E. 2002. The annotation of RNA motifs. Comp Funct Genomics 3:518–524. doi: 10.1002/cfg.213. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIG S1

Sequence alignment of computationally identified viruses comprising a Dianthovirus-like xrRNA (Stockholm format). Download FIG S1, TIF file, 12.6 MB (12.9MB, tif) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Predicted secondary structure diagrams for biochemically tested xrRNAD. Results of RT mapping of Xrn1 halt sites are shown for OPMV and MYDV-RMV. RCNMV data are from a previously published article (A. L. Steckelberg, B. M. Akiyama, D. A. Costantino, T. L. Sit, et al., PNAS 115:6404–6409, 2018). Download FIG S2, JPG file, 0.3 MB (334.3KB, jpg) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S1

Complete list of computationally identified viruses comprising a Dianthovirus-like xrRNA. Download Table S1, PDF file, 1.2 MB (1.2MB, pdf) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S3

Variable genomic location of xrRNAD among plant viruses. (Left) Schematic genomic organization of plant virus genera that harbor xrRNAD elements. xrRNAD are depicted as red hexagons. Genomes are drawn to scale. (Right) sgRNAs or putative sgRNAs that would arise through incomplete degradation of the viral genome by 5´-to-3´ exoribonucleases. Note that the 5´ end of a sgRNA coincides with the 5´ end of xrRNAD for Dianthovirus and Machlomovirus; the mapped 5´ ends of sgRNAs are slightly upstream of the xrRNAD (indicated by dashed line) for Polerovirus and Umbravirus, suggesting that additional trimming events might be involved in sgRNA production. The asterisk indicates a second xrRNAD element that was bioinformatically identified in OPMV but has not been tested biochemically. All other xrRNAD elements depicted here have been biochemically verified in vitro. Download FIG S3, JPG file, 0.5 MB (563.4KB, jpg) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S4

Alignments. Download FIG S4, PDF file, 0.3 MB (282.8KB, pdf) .

Copyright © 2018 Steckelberg et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Data Availability Statement

All data are available from us.


Articles from mBio are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES